Nancy Eulalie Sylvain Van Osselaer

Title: Nancy Eulalie Sylvain Van Osselaer: Innovator in Metabotropic Glutamatergic Receptor Research

Introduction

Nancy Eulalie Sylvain Van Osselaer is a prominent inventor based in Lier, Belgium. She has made significant contributions to the field of pharmacology, particularly in the area of metabotropic glutamatergic receptors. With a total of four patents to her name, her work has the potential to impact therapeutic approaches for various neurological conditions.

Latest Patents

Her latest patents focus on combinations that include positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2. These inventions relate to the use of a positive allosteric modulator ('PAM') of metabotropic glutamatergic receptor subtype 2 (“mGluR2”) or a pharmaceutically acceptable salt or solvate thereof. Additionally, they encompass orthosteric agonists of metabotropic glutamatergic receptor subtype 2 compounds, along with synaptic vesicle protein 2A (“SV2A”) ligands.

Career Highlights

Nancy is currently employed at Janssen Pharmaceutica NV, a leading pharmaceutical company known for its innovative research and development. Her work at Janssen has allowed her to explore new therapeutic avenues and contribute to advancements in the treatment of neurological disorders.

Collaborations

Throughout her career, Nancy has collaborated with notable colleagues, including Brian D Klein and Hilde Lavreysen. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Nancy Eulalie Sylvain Van Osselaer is a distinguished inventor whose work in metabotropic glutamatergic receptor research is paving the way for new therapeutic strategies. Her contributions to the field are invaluable and continue to inspire innovation in pharmacology.